Dose adjustment based on the plasma level measurement used anti-FXa chromogenic assay on the use of non-vitamin K antagonist oral anticoagulants (NOACs) improved the overall benefit of NOACs dosing in patients with atrial fibrillation: Authors' reply.
2021
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
4
References
1
Citations
NaN
KQI